| |
|
|
| Name: |
SUPERSTRING CAPITAL MANAGEMENT LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10022 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
12 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
CYTK |
Cytokinetics Inc |
1 |
- |
$48.41 |
$19,555,000 |
278,915 |
12.93% |
4,727,000 |
101,312 |
0.228 |
Biotechnology |
|
|
NKTX |
Nkarta, Inc. |
2 |
- |
$0.00 |
$12,855,000 |
1,189,193 |
8.5% |
10,562,000 |
841,812 |
2.444 |
N/A |
|
|
BBIO |
Bridgebio Pharma, Inc. |
4 |
- |
$27.13 |
$10,930,000 |
353,507 |
7.23% |
2,601,000 |
147,181 |
0.203 |
N/A |
|
|
SVRA |
Savara Inc |
5 |
- |
$4.02 |
$10,284,000 |
2,065,144 |
6.8% |
6,457,000 |
1,250,878 |
1.526 |
Biotechnology |
|
|
FATE |
Fate Therapeutics Inc |
7 |
- |
$3.66 |
$6,756,000 |
920,476 |
4.47% |
3,585,000 |
72,653 |
0.777 |
Biotechnology |
|
|
ROIV |
Roivant Sciences Ltd. |
9 |
- |
$10.73 |
$5,597,000 |
531,019 |
3.7% |
1,934,000 |
204,858 |
0.077 |
N/A |
|
|
MRNS |
Marinus Pharmaceuticals Inc |
11 |
- |
$1.44 |
$5,113,000 |
565,550 |
3.38% |
86,000 |
103,106 |
1.016 |
N/A |
|
|
URGN |
Urogen Pharma Ltd. |
13 |
- |
$13.08 |
$4,324,000 |
288,267 |
2.86% |
493,000 |
32,837 |
1.305 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
14 |
- |
$0.00 |
$4,173,000 |
259,383 |
2.76% |
1,707,000 |
135,343 |
0.321 |
N/A |
|
|
AXSM |
Axsome Therapeutics, Inc. |
17 |
- |
$72.24 |
$2,921,000 |
36,607 |
1.93% |
1,633,000 |
20,428 |
0.077 |
N/A |
|
|
ALLO |
Allogene Therapeutics, Inc. |
20 |
- |
$0.00 |
$2,330,000 |
521,249 |
1.54% |
1,617,000 |
299,137 |
0.372 |
N/A |
|
|
SPRB |
Spruce Biosciences, Inc. |
35 |
- |
$0.00 |
$346,000 |
440,225 |
0.23% |
-2,000 |
321,411 |
1.178 |
N/A |
|
